article thumbnail

Cannabis Tied to Lower Blood Pressure in Hypertension Patients, Study Finds

The Cannigma

Using cannabis for several months is associated with a reduction in blood pressure among older adults with hypertension, according to a prospective study published last week. The mean differences in 24-hours systolic and diastolic blood pressures were 5.0 No relationship between THC, CBD levels and blood pressure change.

article thumbnail

THC & CBD-Rich Cannabis for Fibromyalgia

Project CBD

Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. No single drug yet exists to address all of the disease’s effects on the body, which can include widespread aches and pains, sleeplessness, fatigue, anxiety, and depression.

THC 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Viagra, Cialis, Or Levitra: Is One Best For Treating Erectile Dysfunction?

Cannabis Law Report

Surprisingly, Viagra came to be after a medication intended to manage blood pressure failed but increased blood flow to the penis. The prescription drug was the first ED drug approved for once-a-day use in 2008. Do not take Levitra alongside nitrate drugs as this will cause a sudden drastic blood pressure drop.

article thumbnail

What is THC? Here’s everything you need to know

The Cannigma

Depending on the state you’re in, THC products may be legally accessible to any adult, and other states restrict access to medical patients only. Many states that disagreed with the federal approach to cannabis started their own medical marijuana programs, and made it accessible for patients. in 2008, 12% in 2012 and 15% in 2018.

THC 98
article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Side effects were very prevalent in 79% of all patients taking a refined CBD product, some of which were severe like thrombocytopenia and transaminase elevations in the liver. Review: During an open-label trial of pure CBD with Lennox-Gastaut and Dravet patients, 79% of all patients reported side effects.